Mgr. Michal Uher
Researcher, Institute of Biostatistics and Analyses
Total number of publications: 50
2015
-
Léčba revmatoidní artritidy preparáty biologické léčby v České republice: Základní přehled a hodnocení účinnosti a bezpečnosti léčby z dat registru ATTRA
Year: 2015
-
Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study
Arthritis Research & Therapy, year: 2015, volume: 17, edition: 341, DOI
2014
-
A Comparison of Baseline Characteristics and Real-Life Effectiveness of Anti-TNF Therapy in Non-Radiographic Axial Spondyloarthritis Versus Ankylosing Spondylitis - a Single Center Cohort Study
Year: 2014, type: Conference abstract
-
A Tailored Approach to Reduce Dose of Anti-TNF Drugs Is Equally Effective, but Substantially Less Costly Than Standard Dosing in Patients with Ankylosing Spondylitis over One Year: A Propensity Score-Matched Cohort Study.
Year: 2014, type: Conference abstract
-
A Tailored Approach to Reduce Dose of TNF Inhibitors Is Equally Effective, but Substantially Less Costly Than Standard Dosing in Patients with Rheumatoid Arthritis over One and Two Years: A Prospective Cohort Study.
Year: 2014, type: Conference abstract
-
Biologic Treatment of Adult Patients with Juvenile Idiopathic Arthritis Followed in the National Registry.
Year: 2014, type: Conference abstract
-
Efficacy of First Line Biological Monotherapy in RA: Data from the Czech Registry Attra
Year: 2014, type: Conference abstract
-
Hodnocení skóre užitku EQ-5D a odhad nákladové užitečnosti prvního roku léčby inhibitory TNF u pacientů s revmatoidní artritidou – výsledky analýzy z národního registru biologické léčby ATTRA
Česká revmatologie, year: 2014
-
Klinický registr AMADEuS – Analytická zpráva a přehled stavu registru k 22. 9. 2014
Year: 2014
-
Léčba revmatoidní artritidy infliximabem (Remicade®) v České republice: Základní přehled a hodnocení účinnosti a bezpečnosti léčby z dat registru ATTRA
Year: 2014